Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
154.06
-1.86 (-1.19%)
At close: Aug 28, 2026, 4:00 PM EDT
154.94
+0.88 (0.57%)
After-hours: Aug 28, 2026, 7:45 PM EDT

Neurocrine Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
332.4713233251.1262.9340.8
Short-Term Investments
57.4767.4843.1780.5726.4370.5
Cash & Short-Term Investments
389.81,4801,0761,032989.3711.3
Cash Growth
-60.05%37.57%4.31%4.28%39.08%-11.20%
Receivables
887686.8479.1439.3350185.5
Inventory
104.26957.438.335.130.5
Prepaid Expenses
217.1170.748.5---
Other Current Assets
39.4115.863.697.879.145.5
Total Current Assets
1,6382,5231,7251,6071,454972.8
Property, Plant & Equipment
538.5545.2592347.3145.6155.8
Long-Term Investments
239.21,184864.3849.4401.5624.4
Goodwill
500.6--5.85.4-
Other Intangible Assets
2,226--35.537.2-
Long-Term Deferred Tax Assets
8.9320.3485.7362.6305.9315.1
Other Long-Term Assets
208.459.55243.819.64.4
Total Assets
5,3594,6323,7193,2512,3692,073

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
142104.999.9133.367.351.5
Accrued Expenses
551.7501.4351.7315.5271.3111.6
Current Portion of Long-Term Debt
---170.1169.4-
Current Portion of Leases
59.856----
Current Income Taxes Payable
114.66810-9-
Current Unearned Revenue
-----62.7
Other Current Liabilities
6.413.146.135.920.720
Total Current Liabilities
874.5743.4507.7654.8537.7245.8
Long-Term Debt
-----335.1
Long-Term Leases
401.8415.3455.1258.393.5105.3
Other Long-Term Liabilities
297.7219.7166.2106.329.712.3
Total Liabilities
1,6661,3781,1291,019660.9698.5

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.10.10.1
Additional Paid-In Capital
2,9642,7922,5552,3822,1222,011
Retained Earnings
724447.729.2-157.1-406.8-635.8
Comprehensive Income & Other
5.113.15.87-7.9-1.7
Shareholders' Equity
3,6943,2532,5902,2321,7081,374
Total Liabilities & Equity
5,3594,6323,7193,2512,3692,073

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
461.6471.3455.1428.4262.9440.4
Net Cash (Debt)
-71.81,009621603.2726.4270.9
Net Cash Growth
-62.50%2.95%-16.96%168.14%-30.31%
Net Cash Per Share
-0.699.845.995.977.342.77
Filing Date Shares Outstanding
101.65100.3699.799.5196.5995.24
Total Common Shares Outstanding
101.6100.199.498.796.594.9
Working Capital
7631,7791,217952.2915.8727
Book Value Per Share
36.3532.5026.0522.6117.7014.48
Tangible Book Value
9673,2532,5902,1911,6651,374
Tangible Book Value Per Share
9.5232.5026.0522.2017.2614.48
Machinery
-172.5153.2115.78775.6
Leasehold Improvements
-35.635.938.137.934.9
SEC Filings: 10-K · 10-Q